These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 17547995

  • 1. Combined modality therapy of esthesioneuroblastoma.
    McLean JN, Nunley SR, Klass C, Moore C, Müller S, Johnstone PA.
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
    [Abstract] [Full Text] [Related]

  • 2. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M, Constantinidis J, Dimmler A, Strauss C, Iro H.
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [Abstract] [Full Text] [Related]

  • 3. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A, Dutra J, Tseke P, Haines K.
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [Abstract] [Full Text] [Related]

  • 4. Esthesioneuroblastoma: the University of Iowa experience 1978-1998.
    Simon JH, Zhen W, McCulloch TM, Hoffman HT, Paulino AC, Mayr NA, Buatti JM.
    Laryngoscope; 2001 Mar; 111(3):488-93. PubMed ID: 11224781
    [Abstract] [Full Text] [Related]

  • 5. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
    Eich HT, Müller RP, Micke O, Kocher M, Berthold F, Hero B.
    Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
    [Abstract] [Full Text] [Related]

  • 6. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT, Hero B, Staar S, Micke O, Seegenschmiedt H, Mattke A, Berthold F, Müller RP.
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [Abstract] [Full Text] [Related]

  • 7. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M, Gruber G, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M, Kaanders JH, Cengiz M, Krengli M, Matzinger O, Zouhair A.
    Int J Radiat Oncol Biol Phys; 2010 Nov 15; 78(4):992-7. PubMed ID: 20231062
    [Abstract] [Full Text] [Related]

  • 8. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT, Hinerman RW, Amdur RJ, Morris CG, Mendenhall WM.
    Head Neck; 2003 Jul 15; 25(7):529-34. PubMed ID: 12808655
    [Abstract] [Full Text] [Related]

  • 9. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
    Rastogi M, Bhatt M, Chufal K, Srivastava M, Pant M, Srivastava K, Mehrotra S.
    Jpn J Clin Oncol; 2006 Oct 15; 36(10):613-9. PubMed ID: 16926225
    [Abstract] [Full Text] [Related]

  • 10. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J, Steinhart H, Koch M, Buchfelder M, Schaenzer A, Weidenbecher M, Iro H.
    Otolaryngol Head Neck Surg; 2004 May 15; 130(5):567-74. PubMed ID: 15138422
    [Abstract] [Full Text] [Related]

  • 11. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.
    Diaz EM, Johnigan RH, Pero C, El-Naggar AK, Roberts DB, Barker JL, DeMonte F.
    Head Neck; 2005 Feb 15; 27(2):138-49. PubMed ID: 15654688
    [Abstract] [Full Text] [Related]

  • 12. Esthesioneuroblastoma: The Princess Margaret Hospital experience.
    Bachar G, Goldstein DP, Shah M, Tandon A, Ringash J, Pond G, Gullane PJ, Perez-Ordonez B, Gilbert RW, Brown DH, Gentili F, O'Sullivan B, Irish JC.
    Head Neck; 2008 Dec 15; 30(12):1607-14. PubMed ID: 18798301
    [Abstract] [Full Text] [Related]

  • 13. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
    Kim HJ, Kim CH, Lee BJ, Chung YS, Kim JK, Choi YS, Yoon JH.
    Auris Nasus Larynx; 2007 Dec 15; 34(4):493-8. PubMed ID: 17499464
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic factors and outcome of esthesioneuroblastoma].
    Zhao LJ, Gao L, Xu GZ, Li SY, Xiao GL.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep 15; 27(9):561-4. PubMed ID: 16438858
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patterns of failure and outcome in esthesioneuroblastoma.
    Dias FL, Sa GM, Lima RA, Kligerman J, Leoncio MP, Freitas EQ, Soares JR, Arcuri RA.
    Arch Otolaryngol Head Neck Surg; 2003 Nov 15; 129(11):1186-92. PubMed ID: 14623748
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of intracranial metastatic esthesioneuroblastoma.
    Chamberlain MC.
    Cancer; 2002 Jul 15; 95(2):243-8. PubMed ID: 12124822
    [Abstract] [Full Text] [Related]

  • 20. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
    El Kababri M, Habrand JL, Valteau-Couanet D, Gaspar N, Dufour C, Oberlin O.
    J Pediatr Hematol Oncol; 2014 Mar 15; 36(2):91-5. PubMed ID: 24390450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.